Like shares, leaps, and September 20th 25C's at .65 a contract

RNA company with one of the largest pipelines in the industry, biotech sector likely to see a tailwind in markets with rates coming down over the next 12 months
Chart PatternsTechnical Indicators

Auch am:

Haftungsausschluss